Acer Therapeutics and Relief Therapeutics Announce Receipt o

Relief Therapeutics Holding SA / Key word(s): Patent Acer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of US Patent Application Covering a Kit Comprising Phenylbutyrate and Sodium Benzoate 03-Oct-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to ...

Related Keywords

Geneva , Genè , Switzerland , Secheron , Switzerland General , United States , Swiss , Irina Koffler , Jim Denike , Nick Colangelo , Jeff Davis , Jack Weinstein , Advita Lifescience Gmb , Relief Therapeutics Holding Sa Key , Pharma Research , Drug Administration , Swiss Exchange , Nasdaq , Exchange Commission , Trademark Office , Gilmartin Group , European Medicines Agency , Relief Therapeutics Holding , News Service , Acer Therapeutics Inc , Baylor College Of Medicine , Relief Therapeutics Announce Receipt , Application Covering , Kit Comprising Phenylbutyrate , Sodium Benzoate , Acer Therapeutics , Baylor College , Chief Business Officer , Maple Syrup Urine Disease , Vasomotor Symptoms , License Agreement , New Drug Application , Advita Lifescience Gmbh , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Financial Officer , Announce , Receipt , Notice , Allowance , Us , Patent , Application , Covering , It , Comprising , Henylbutyrate , Podium , Enzoate , Et Cest , Release ,